With fewer smaller chemicals, scientists develop more-targeted medicines

Innovative animal-free cell culture improves consistency, safety, and efficiency

Lonza Walkersville’s new Silensomes™ HLM products provide researchers a fully characterized pre-made solution for CYP phenotyping, resulting in more consistent and reliable results

The journey from lead discovery to final approval can be long and challenging

New informatics solution for biologics discovery helps multidisciplinary and multi-organizational teams capture and track projects

New drugs to treat depression in particular are needed because many existing antidepressants don't work in up to 50 percent of patients

The need for tougher controls as regulators hold labs to ever higher standards

Findings could help predict which patients will suffer side effects and prevent complications in susceptible patients

Anticancer drug costs in the United States increase substantially after launch regardless of competition, according to a new study

New gene drive targeting a fungal pathogen enables identification of virulence regulators and potential future combination therapies

In recent years, researchers have learned more—largely through 3D atomic structures—about how G protein-coupled receptors are built and thus how they function

Antibiotics work in different ways, but some can attack the very basic process of making new proteins in bacterial cells